News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

MTX treatment break improves COVID-19 booster response in patients with IMIDs
18 Aug 2022
byAudrey Abella
In individuals with immune-mediated inflammatory diseases (IMIDs*), a 2-week interruption in methotrexate (MTX) treatment led to enhanced COVID-19 booster vaccine response compared with those who continued with MTX treatment, according to findings from the VROOM** study.
18 Aug 2022

Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
16 Aug 2022
byRoshini Claire Anthony
A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.
16 Aug 2022






